References
- American Thoracic Society. Fungal infection in HIV-infected persons. Am J Respir Crit Care Med. 1995;152:816–822.
- Anesi JA, Baddley JW. Approach to the solid organ transplant patient with suspected fungal infection. Infect Dis Clin North Am. 2016;30(1):277–296.
- Richardson MD, Kokki MH. Diagnosis and prevention of fungal infection in the immunocompromized patient. Blood Rev. 1998;12(4):241–254.
- Suleyman G, Alangaden GJ. Nosocomial fungal infections: epidemiology, infection control, and prevention. Infect Dis Clin North Am. 2016;30(4):1023–1052.
- Gilroy SA, Bennett NJ. Pneumocystis pneumonia. Semin Respir Crit Care Med. 2011;32(6):775–782.
- Mathew BS, Grossman SA. Pneumocystis carinii pneumonia prophylaxis in HIV negative patients with primary CNS lymphoma. Cancer Treat Rev. 2003;29(2):105–119.
- Fishman JA. Treatment of infection due to Pneumocystis carinii. Antimicrob Agents Chemother. 1998;42(6):1309–1314.
- Weyant RB, Kabbani D, Doucette K, et al. Pneumocystis jirovecii: a review with a focus on prevention and treatment. Expert Opin Pharmacother. 2021;22(12):1579–1592.
- Denning DW. Echinocandin antifungal drugs. Lancet. 2003;362(9390):1142–1151.
- Bae JM. A suggestion for quality assessment in systematic reviews of observational studies in nutritional epidemiology. Epidemiol Health. 2016;38:e2016014.
- Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
- Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
- Tian Q, Si J, Jiang F, et al. Caspofungin combined with TMP/SMZ as a first-line therapy for moderate-to-severe PCP in patients with human immunodeficiency virus infection. HIV Med. 2021;22(4):307–313.
- Jin F, Liu XH, Chen WC, et al. High initial (1, 3) beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia. Int J Infect Dis. 2019;88:141–148.
- Sun QG, Zhang HY, Liu N, et al. Clinical analysis of 7 cases suffered pneumocystis pneumonia in non-HSCT patients with hematological diseases. Chin J Mycol. 2020;15:344–348.
- Wang MY, Lang GJ, Chen Y, et al. A pilot study of echinocandin combination with trimethoprim/sulfamethoxazole and clindamycin for the treatment of AIDS patients with Pneumocystis pneumonia. J Immunol Res. 2019;2019:8105075.
- Lu YM, Lee YT, Chang HC, et al. Combination of echinocandins and trimethoprim/sulfamethoxazole for the treatment of Pneumocystis jiroveci pneumonia after heart transplantation. Transplant Proc. 2017;49(8):1893–1898.
- Chang HC, Yang WT, Chen TC. Pneumocystis jirovecii pneumonia in a human immunodeficiency virus-infected patient with G6PD deficiency-successful treatment with anidulafungin. Eur Rev Med Pharmacol Sci. 2018;22(24):8961–8964.
- Sun PP, Tong ZH. Efficacy of caspofungin, a 1,3-beta-D-glucan synthase inhibitor, on Pneumocystis carinii pneumonia in rats. Med Mycol. 2014;52(8):798–803.
- Koshy R, Chen T. Combination therapy with trimethoprim-sulfamethoxazole and caspofungin in a case of severe pneumocystis pneumonia. IDCases. 2019;15:e00496.
- Lobo ML, Esteves F, Sousa BD, et al. Therapeutic potential of caspofungin combined with trimethoprim-sulfamethoxazole for pneumocystis pneumonia: a pilot study in mice. PLoS One. 2013;8(8):e70619.
- Tu GW, Ju MJ, Xu M, et al. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients. Nephrology (Carlton). 2013;18(11):736–742.
- Smego RAJ, Nagar S, Maloba B, et al. A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia. Arch Intern Med. 2001;161(12):1529–1533.
- Briel M, Boscacci R, Furrer H, et al. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection: a meta-analysis of randomised controlled trials. BMC Infect Dis. 2005;5(1):101.